Compass Therapeutics to Participate in Upcoming November Investor Events

Core Viewpoint - Compass Therapeutics, Inc. is actively participating in several investor events in November 2025 to showcase its oncology-focused biopharmaceutical developments [1][2]. Company Overview - Compass Therapeutics is a clinical-stage biopharmaceutical company founded in 2014, headquartered in Boston, Massachusetts, focusing on developing proprietary antibody-based therapeutics for multiple human diseases [3]. - The company emphasizes the relationship between angiogenesis, the immune system, and tumor growth, aiming to create a robust pipeline of novel product candidates [3]. - Its product candidates are designed to target critical biological pathways for effective anti-tumor responses, including modulation of microvasculature, induction of immune responses, and alleviation of immunosuppressive mechanisms [3]. Upcoming Investor Events - Compass will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference on November 10, 2025, at 3:30 PM ET in Boston, MA [2]. - The company will also attend the Stifel 2025 Healthcare Conference on November 12, 2025, at 4:00 PM ET in New York, NY [2]. - Additionally, Compass is set to present at the Jefferies Global Healthcare Conference on November 20, 2025, at 12:00 PM GMT in London, UK [2]. - Presentations from these events will be archived for 90 days on Compass' Events page [2].